Catalyst Wire Dossier Catalyst Wire Dossier

Refludan

lepirudin · Celgene Europe Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Refludan, covering 2012-07-27 to 2012-07-27. Get the full timeline:

Most recent: EMA Withdrawn: Refludan (lepirudin) — Celgene Europe Ltd.

See pricing